Akèy › VIH › Distrik Columbia › Washington
Etid klinik pou VIH nan Washington, DC
22 etid pou VIH ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
Ap rekriteFaz 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Viral Load in Blood and Lymph Tissues in People Living With HIV
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
Ap rekriteFaz 3
- GSK Investigational Site, Washington D.C.
Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
Ap rekriteFaz 1/2Volontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
El Camino HIV Prevention and Care Study
Ap rekrite
- La Clínica del Pueblo, Washington D.C.
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Ap rekriteFaz 2/3
- Whitman-Walker Institute ( Site 1538), Washington D.C.
Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
Ap rekriteFaz 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
Ap rekriteFaz 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma
Ap rekriteFaz 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
Ap rekrite
- George Washington University, Washington D.C.
Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy
Ap rekriteFaz 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Ap rekriteEtid obsèvasyon
- George Washington University, Washington D.C.
The DC Cohort Longitudinal HIV Status Neutral Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Kaiser Permanente Mid-Atlantic States, Washington D.C.
- Unity Health Care, Washington D.C.
- Georgetown University, Washington D.C.
- ak 11 plis
Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)
Ap rekriteVolontè an sante akeyi
- HIPS (Harm reduction drop-in center), Washington D.C.
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
Ap rekriteFaz 1/2
- GSK Investigational Site, Washington D.C.
Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
Ap rekriteVolontè an sante akeyi
- Whitman-Walker Health, Washington D.C.
Etid VIH nan lòt vil
- New York City, NY19 etid
- Houston, TX17 etid
- Miami, FL17 etid
- Baltimore, MD16 etid
- San Francisco, CA15 etid
- Chicago, IL14 etid
- Atlanta, GA14 etid
- Philadelphia, PA11 etid
- Boston, MA11 etid
- San Diego, CA10 etid
- Los Angeles, CA9 etid
- Seattle, WA8 etid
Lòt etid nan Washington
- Kansè (tout kalite)58 etid
- Kansè Poumon ki pa ti selil55 etid
- Kansè nan tete46 etid
- Kansè Metastatik43 etid
- Kansè poumon41 etid
- Kansè pwostat38 etid
- Obèsite33 etid
- Kansè kolorektal29 etid
- Maladi kadyovaskilè28 etid
- Kansè vejik26 etid
- Leksemi mieloïd egi24 etid
- Kansè ovè23 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.